Three-Dose Regimen of MRKAd5+6 Trigene (V526) in Healthy Adults (V526-001)(COMPLETED)

Clinical trial NCT00850616 · COMPLETED

Trial details

NCT number: NCT00850616
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HIV HIV Infections

Start date: 2005-04-01
Primary completion: 2006-08-01
Enrollment: 147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.